Prekallikrein (PK) deficiency was first reported in the USA by Hathaway et al. in 1965. 1 The defect was a new asymptomatic condition despite the presence of a prolonged Partial Thromboplastin Time (PTT). After that description several cases were reported but the defect never stimulated a widespread interest. The total number of reported cases in the USA is about 60. 2-4 However, some of these were just listed as cases and no medical history was supplied. 2 It is also likely that some of these cases were subsequently reported as case studies. 3 The aim of this Letter is to call the attention of the readers to the fact that up to now only a few patients with this disorder have been investigated by molecular study.